L P Quinn

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. request reprint
    Quinn L, Perren M, Brackenborough K, Woodhams P, Vidgeon Hart M, Chapman H, et al. A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(-)-deprenyl. J Neurosci Methods. 2007;164:43-9 pubmed
    ..The data described in the present study provides further evidence that functional deficits following an acute MPTP dosing schedule in mice can be quantified and are related to nigro-striatal dopamine function. ..

Detail Information

Publications1

  1. request reprint
    Quinn L, Perren M, Brackenborough K, Woodhams P, Vidgeon Hart M, Chapman H, et al. A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(-)-deprenyl. J Neurosci Methods. 2007;164:43-9 pubmed
    ..The data described in the present study provides further evidence that functional deficits following an acute MPTP dosing schedule in mice can be quantified and are related to nigro-striatal dopamine function. ..